The US Food and Drug Administration declined to grant accelerated approval to an experimental Alzheimer’s drug, donanemab, and requested additional data from Eli Lilly and Company, the drug maker.
• Opinion: One problem in Biden’s first year • Battered White House searches...
Share this (SOURCE) https://www.cnn.com/2022/01/05/cnn-underscored/money/should-i-refinance-my-mortgage/index.html?iid=CNNUnderscoredHPcontainer
Your email address will not be published. Required fields are marked *
Add Comment *